JMIR Biomedical Engineering
Engineering for health technologies, medical devices, and innovative medical treatments and procedures.
Editor-in-Chief:
Javad Sarvestan, PhD, Scientific Editor at JMIR Publications, Canada
Recent Articles

Brain-Computer Interface (BCI) closed-loop systems have emerged as a promising tool in healthcare and wellness monitoring, particularly in neurorehabilitation and cognitive assessment. With the increasing burden of neurological disorders, including Alzheimer’s Disease and Related Dementias (AD/ADRD), there is a critical need for real-time, non-invasive monitoring technologies. BCIs enable direct communication between the brain and external devices, leveraging artificial intelligence (AI) and machine learning (ML) to interpret neural signals. However, challenges such as signal noise, data processing limitations, and privacy concerns hinder widespread implementation. This review explores the integration of ML and AI in BCI closed-loop systems, evaluating their effectiveness in improving neurological assessments and interventions.

Adapting physical activity monitors to detect gait events (initial & final contact) has the potential to build a more personalised approach to gait rehabilitation after stroke. Meeting laboratory standards for detecting these events in impaired populations is challenging without resorting to a multi-sensor solution. The Teager-Kaiser Energy Operator (TKEO) estimates the instantaneous energy of a signal; its enhanced sensitivity has successfully detected gait events from the acceleration signals of individuals with impaired mobility, but has not been applied to stroke.


Implantable Medical Devices (IMDs), such as pacemakers, increasingly communicate wirelessly with external devices. To secure this wireless communication channel, a pairing process is needed to bootstrap a secret key between the devices. Previous work has proposed pairing approaches that often adopt a “seamless” design and render the pairing process imperceptible to patients. This lack of user perception can significantly compromise security and pose threats to patients.

Accurately assessing pain severity is essential for effective pain treatment and desirable patient outcomes. In clinical settings, pain intensity assessment relies on self-reporting methods, which are subjective to individuals and impractical for non-communicative or critically ill patients. Previous studies have attempted to measure pain objectively using physiological responses to an external pain stimulus, assuming that the human subject is free of internal body pain. However, this approach does not reflect the situation in a clinical setting, where a patient subjected to an external pain stimulus may already be experiencing internal body pain.

Acoustic biomarkers derived from speech signals is a promising non-invasive technique for diagnosing Type 2 Diabetes Mellitus (T2DM). Despite its potential, there remains a critical gap in knowledge regarding the optimal number of voice recordings and recording schedule necessary to achieve effective diagnostic accuracy.

Cardiovascular diseases (CVDs) are the leading cause of death globally, and almost one-half of all adults in the United States have at least one form of heart disease. This review focused on advanced technologies, genetic variables in CVD, and biomaterials used for organ-independent cardiovascular repair systems.

Exercise is essential for physical rehabilitation, helping to improve functional performance and manage chronic conditions. Telerehabilitation offers an innovative way to deliver personalized exercise programs remotely, enhancing patient adherence and clinical outcomes. The Home Automated Telemanagement (HAT) System, integrated with the interactive bike (iBikE) system, was designed to support home-based rehabilitation by providing patients with individualized exercise programs that can be monitored remotely by a clinical rehabilitation team.

Cell concentration in body fluid is an important factor for clinical diagnosis. The traditional method involves clinicians manually counting cells under microscopes, which is labor-intensive. Automated cell concentration estimation can be achieved using flow cytometers; however, their high cost limits accessibility. Microfluidic systems, although cheaper than flow cytometers, still require high-speed cameras and syringe pumps to drive the flow and ensure video quality. In this paper, we present SmartFlow, a low-cost solution for cell concentration estimation using smartphone-based computer vision on 3D-printed, pump-free microfluidic platforms.

Numerous studies have explored image processing techniques aimed at enhancing ultrasound images to narrow the performance gap between low-quality portable devices and high-end ultrasound equipment. These investigations often use registered image pairs created by modifying the same image through methods like down sampling or adding noise, rather than using separate images from different machines. Additionally, they rely on organ-specific features, limiting the models’ generalizability across various imaging conditions and devices. The challenge remains to develop a universal framework capable of improving image quality across different devices and conditions, independent of registration or specific organ characteristics.
Preprints Open for Peer-Review
There are no preprints available for open peer-review at this time. Please check back later.











